The epitome of tailor-made short positively charged peptides against HCC via integrated pharmacology
J Transl Med
.
2024 Mar 15;22(1):279.
doi: 10.1186/s12967-024-05087-w.
Authors
Ki-Kwang Oh
1
,
Jung-A Eom
1
,
Kyeong Jin Lee
1
,
Goo-Hyun Kwon
1
,
Sang-Jun Yoon
1
,
Seol Hee Song
1
,
Jeong Ha Park
1
,
Jeong Su Kim
1
,
Dong Joon Kim
1
,
Ki-Tae Suk
2
Affiliations
1
Institute for Liver and Digestive Diseases, College of Medicine, Hallym University, Chuncheon, 24252, Korea.
2
Institute for Liver and Digestive Diseases, College of Medicine, Hallym University, Chuncheon, 24252, Korea. ktsuk@hallym.ac.kr.
PMID:
38491465
PMCID:
PMC10941355
DOI:
10.1186/s12967-024-05087-w
No abstract available
Publication types
Letter
MeSH terms
Carcinoma, Hepatocellular* / drug therapy
Humans
Liver Neoplasms* / drug therapy
Peptides / pharmacology
Peptides / therapeutic use
Substances
Peptides
Grants and funding
NRF2019R1I1A3A01060447/The Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology
NRF-2020R1A6A1A03043026/The Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology
P0020622/Korea Institute for Advancement of Technology funded by the Ministry of Trade, Industry and Energy (MOTIE, Korea)
20018494/Bio Industrial Technology Development Program funded by the Ministry of Trade, Industry and Energy (MOTIE, Korea)